Try our Advanced Search for more refined results

Apotex Inc. et al v. Allergan Inc.

  1. April 26, 2017

    Allergan Settles Apotex Pinkeye Meds Product-Hopping Suit

    A Delaware federal judge on Wednesday dismissed a 5-year-old lawsuit alleging Allergan Inc. conspired with other pharmaceutical companies to stifle competition for its Zymar pinkeye treatment after the company announced it had reached a settlement with generics maker Apotex Inc.

  2. January 06, 2017

    Kyorin To Settle Apotex Pinkeye Meds Product-Hopping Suit

    Apotex has agreed to settle its antitrust claims against Japanese drug manufacturer Kyorin Pharmaceutical in a suit accusing multiple drugmakers of trying to extend their hold over the market for Allergan Inc.'s Zymar pinkeye treatment, according to court documents filed Friday.

  3. May 24, 2016

    Senju Settles Out Of Apotex's Pinkeye Meds Antitrust Suit

    Apotex has reached a settlement to resolve its claims against Senju Pharmaceutical in an antitrust suit accusing multiple drugmakers of trying to extend the patent for Allergan Inc.'s Zymar pinkeye treatment, according to a stipulation approved Tuesday in a Delaware federal court.

  4. May 01, 2015

    Antitrust Suit Over Allergan Pink-Eye Meds Heads For Trial

    An antitrust suit accusing Allergan Inc. of trying to extend the patent for its Zymar pink-eye treatment by marketing a nearly identical reformulation will continue to trial, a Delaware federal judge decided Friday, finding that a competitor presented enough evidence to continue.

  5. May 25, 2012

    Allergan, Others Look To Ice Apotex Monopoly Suit

    Allergan Inc. and two Japanese drug makers urged a Delaware federal court Thursday to pause Apotex Inc.'s monopolization suit over Allergan's decision to market a new formulation of Zymar until an underlying patent dispute between the companies over the eye infection medication is resolved.

  6. February 21, 2012

    Allergan, Others Sought Pinkeye Treatment Monopoly: Suit

    Generic pharmaceutical manufacturer Apotex Inc. launched a suit in Delaware Thursday accusing Allergan Inc. and two Japanese drug manufacturers of pinkeye medication Zymar of creating a monopoly over the medication and creating a new version of the treatment to eliminate generic competition.